PRP care in Peoria begins with an exam

The clinic is near Thunderbird Road and Loop 101

QC Kinetix (Peoria) is at 13128 N. 94th Dr., Suite 205, Peoria, AZ 85381, near Thunderbird Road and Loop 101. The clinic number is (602) 837-PAIN, or (602) 837-7246.

For this visit, the letters PRP mean platelet-rich plasma: your blood is separated, and plasma with platelets, blood cells involved when bleeding stops, is kept. That's the blood-based part of the visit.

The Peoria office of QC Kinetix provides regenerative treatment options, meaning its clinicians examine the sore joint before the clinic prepares care from your blood. You can ask why a particular option is offered.

Travel time changes across Peoria

Peoria stretches from Olive Avenue to beyond Lake Pleasant, so the drive can vary quite a bit depending on which part of town you leave from and the traffic. North Peoria may mean more time on the road.

You can ask how long the visit takes and whether someone needs to drive you home. It's also fair to ask when follow-up happens.

A hot, badly swollen joint or a sudden loss of weight-bearing needs prompt medical care. Routine visit planning isn't enough then.

Your regular activity guides the recovery talk

Tell the clinician whether golf, walking, driving, or lifting brings on the soreness, and how long you can do it before the ache begins. That gives the recovery talk a useful starting point.

You can ask what remains comfortable and what may need a brief pause. You'll also want to know when to call.

Care right before a trip or important event may make those first days harder to arrange. A little planning can help.

Sources

1. The 2019 ACR/Arthritis Foundation osteoarthritis guideline makes STRONG recommendations for exercise, weight loss in people with overweight or obesity, self-management programmes, tai chi, cane use, tibiofemoral bracing, topical and oral NSAIDs and intra-articular glucocorticoid injections for knee OA. Its conditional recommendations cover balance exercises, yoga, CBT, acupuncture, thermal modalities, radiofrequency ablation, acetaminophen, duloxetine and tramadol. Anything offered before a course of the strongly recommended options is being offered out of order.

   Kolasinski SL, Neogi T, Hochberg MC, et al. — 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis & Rheumatology, 2020. DOI: 10.1002/art.41142.

2. The ESSKA-ICRS consensus applied the RAND/UCLA appropriateness method to 216 clinical scenarios for intra-articular PRP in knee OA. Only 84 scenarios (38.9%) were rated appropriate, 9 (4.2%) inappropriate and 123 (56.9%) uncertain. PRP was judged appropriate in patients aged 80 or under with KL grade 0-III osteoarthritis AFTER failed conservative non-injective or injective treatment; it was NOT considered appropriate as a first treatment, nor in KL grade IV (bone-on-bone) osteoarthritis, where 91.7% and 87.5% of scenarios respectively were uncertain.

   Kon E, de Girolamo L, Laver L, et al. — Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy, 2024. DOI: 10.1002/ksa.12320.

3. Medicare's national coverage policy covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only within an approved coverage-with-evidence-development clinical study. There is no Medicare national coverage for PRP in osteoarthritis or tendinopathy, which is why these injections are billed to the patient as cash-pay.

   Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2024.

4. A systematic review of 105 clinical PRP studies in orthopaedics published 2006-2016 found that only 11 (10%) described the preparation protocol clearly enough for another investigator to repeat it, and only 17 (16%) reported any quantitative metric of the final PRP composition. The authors concluded that the current reporting of PRP preparation and composition does not allow the PRP products actually delivered to patients to be compared between studies.

   Chahla J, Cinque ME, Piuzzi NS, et al. — A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature. Journal of Bone and Joint Surgery (American), 2017. DOI: 10.2106/JBJS.16.01374.